“Profit over Principles? Unpacking the Controversial Alliance Between Medical Professionals, Activist Groups, and The Pharmaceutical Industry in Child Sex Change Debates”

Published on June 22, 2024, 12:43 am

  • Array

Dr. Richard Ogden Roberts III, a pediatric endocrinologist who works at Texas Children’s Hospital, is known for providing puberty-blocking and cross-sex hormone medications to children grappling with gender dysphoria. The doctor found himself embroiled in controversy when he joined numerous radical-activist groups as a plaintiff in a lawsuit aiming to halt legislation against child sex changes. This reliance on his medical expertise has positioned him squarely at the center of an escalating scandal within his place of work.

The hospital itself is under fire, wrapped up in allegations of dishonesty regarding its provision of transgender medical interventions for children—prompting significant public backlash. This scandal was ignited by a whistleblower who disclosed these practices to the public and subsequently became a target for the federal government.

Further accusations complicate matters, as Dr. Roberts now faces claims of committing Medicaid fraud related to his supposed “gender-affirming care” services. According to another whistleblower, Texas Children’s Hospital has been billing Medicaid illegally for these interventions—with Dr. Roberts playing a critical role in the process. These allegations spark additional scrutiny from Texas Attorney General Ken Paxton since use of Medicaid funds for such practices sharply violates state laws.

As an advocate for radical transgender philosophies, Dr.Roberts demonstrates strong partnerships between extreme transgender activists and elements within the medical community. For instance, during one presentation at Texas Children’s Hospital, he emphasized that procedures altering children’s sex were essential and lifesaving–and even made note that he used preferred pronouns and names of “gender diverse” children without parental knowledge or consent.

Participating in lawsuits alongside Dr.Roberts are organizations such as GLMA: Health Professionals Advancing LGBTQ+ Equality—which staunchly promotes child sex change operations—and PFLAG—one of America’s most influential pro-transgender entities—that distributes resources like their “transgender reading list for children”. This developed alliance suggests alignment with more left-leaning ideologies prevalent among specific activist groups and corporations, notably in the pharmaceutical industry.

It is important to highlight that these organizations are largely backed by pharmaceutical companies boasting of numerous products used in sex change processes. GLMA has connections with the Pharmaceutical Research and Manufacturers of America (PhRMA), representing diverse businesses involved in producing drugs for those seeking to adjust sexes such as Abbvie, Bayer, Pfizer, Novo Nordisk, Teva US Speciality Medicines, and Eli Lilly. Even Pfizer Rx Pathways—a division within Pfizer—provides several medications routinely used by individuals looking to transition sex.

Similar to GLMA, PFLAG also receives monetary support from pharmaceutical corporations benefiting from child sex change efforts. One of these, Abbvie Pharmaceuticals manufacturing Lupron Depot—a puberty-blocking drug known for usage in chemical castration—has confirmed its financial backing for PFLAG among other organizations advocating child transgenderism.

Meanwhile, two powerful legal entities associated with pushing transgender rights—the Transgender Law Center and Lambda Legal—have secured funding from respective companies under PhRMA’s umbrella and others like Bayer Pharmaceuticals that offer products utilized in gender transition processes. These ties indicate an increasingly intertwined network between medical professionals, legal institutions, activists groups, and the pharmaceutical industry—all circling around this controversial issue.

As we unpack these complex relationships further; Healthcare advocate January Littlejohn warned about this seemingly unholy alliance last year when she said: “These medical interventions are costly […] It is not surprising that big pharma would partner with an organization aiming to normalize a mental health issue from which they would profit immensely.” As news breaks out about this escalating situation becoming apparent amidst real news sources and trusted news outlets alike—with increasing attention on staggering corporate profits intersecting activist healthcare initiatives—it is vital now more than ever to approach every argument armed with a Christian worldview shaped by ethical, moral principles. This increasingly relevant topic urges a pursuit towards objective understanding while remaining rooted firmly within values representing respect for human dignity and ultimate truth.

Original article posted by Fox News

Be the first to comment on "“Profit over Principles? Unpacking the Controversial Alliance Between Medical Professionals, Activist Groups, and The Pharmaceutical Industry in Child Sex Change Debates”"

Leave a comment

Your email address will not be published.


*